SUN Pharmaceutical Industries Limited Imatinib Export Data — India (DGFT 2022–2026)

Name: SUN Pharmaceutical Industries Limited Imatinib Export Records India — #3 Exporter, 72 Shipments, $2.9M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Imatinib

India Pharmaceutical Trade Intelligence

$29.3M224 Suppliers119 CountriesHS 30049049

ExportsIndia → UNITED STATES24.3%India → BELGIUM12.4%

ImportsGERMANY → India$331.7M UNITED STATES → India$584.7K

#1 Supplier: CIPLA LIMITED #1 Buyer: H.ESSERS &

SUN Pharmaceutical Industries Limited — Imatinib Exporter #3 | $2.9M Trade Value | TransData Nexus | TransData Nexus

SUN Pharmaceutical Industries Limited — Imatinib Exporter Profile

Indian Pharmaceutical Exporter · #3 for Imatinib · $2.9M export value · DGFT Verified

SUN Pharmaceutical Industries Limited is the #3 Indian exporter of Imatinib with $2.9M in export value and 72 verified shipments. SUN Pharmaceutical Industries Limited holds a 9.9% market share in Imatinib exports across 7 countries. The company exports 118 pharmaceutical products worth $979.8M across 25 therapeutic categories.

SUN Pharmaceutical Industries Limited — Imatinib Export Profile: Buyers & Destinations

SUN Pharmaceutical Industries Limited Imatinib export treemap — buyers and destination countries | TransData Nexus

Where Does SUN Pharmaceutical Industries Limited Export Imatinib?

Country	Value	Shipments	Share
UNITED STATES	$864.1K	42	45.3%
AUSTRALIA	$378.1K	8	19.8%
PHILIPPINES	$238.4K	6	12.5%
BELGIUM	$220.2K	9

Who Are the Top Buyers of Imatinib from SUN Pharmaceutical Industries Limited?

Buyer	Country	Value	Orders
SUN PHARMACEUTICAL INDUSTRIES,INC.	UNITED STATES	$396.0K	12
SUN PHARMACEUTICAL INDUSTRIES INC	UNITED STATES	$343.4K	14
SUN PHARMA ANZ PTY LTD.	AUSTRALIA	$278.1K	6
YUSEN LOGISTICS BENELUX BELGIUM	BELGIUM	$220.2K	9
SUN PHARMA PHILIPPINES INC.	PHILIPPINES	$171.1K	4
SUN PHARMA ANZ PTY LTD.,	AUSTRALIA	$100.0K	2
SUN PHARMA PHILIPPINES INC	PHILIPPINES	$67.3K	2
SUN FARMACEUTICA DO BRASIL LTDA.	BRAZIL	$50.0K	1
SUN PHARMACEUTICAL INDUSTRIESINC.	UNITED STATES	$50.0K	1
GRADINTER S.C	MEXICO	$50.0K	1

SUN Pharmaceutical Industries Limited supplies Imatinib to 18 buyers globally. The largest buyer is SUN PHARMACEUTICAL INDUSTRIES,INC. (UNITED STATES), followed by SUN PHARMACEUTICAL INDUSTRIES INC (UNITED STATES) and SUN PHARMA ANZ PTY LTD. (AUSTRALIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Imatinib Formulations Does SUN Pharmaceutical Industries Limited Export?

Product Description / Formulation	Value	Shipments
IMATINIB Mesylate Tablets 400mg PACK : 30s Bottle Batch No. As Per DOCUMENT	$200.0K	4
IMATINIB MESYLATE TABLETS 400MG (IMATINI	$100.0K	2
IMATINIB Mesylate Tablets 400mg PACK : 3	$97.6K	2
IMATINIB MESYLATE TABLETS 100 MG PACK :	$70.8K	4
IMATINIB MESYLATE TABLETS 400MG	$50.0K	1
IMALEK TAB 100MG TABLETS (IMATINIB MESYL	$50.0K	1
IMATINIB Mesylate Tablets 400mg PACK 30s Bottle Batch HAD3314A MFD 16 09 2022 EXP 31 08 2024	$50.0K	1
IMATINIB MESYLATE TABLETS 100MG (IMATINI	$50.0K	1
IMALEK TAB 100MG IMATINIB MESYLATE TABL	$50.0K	1
IMATINIB Mesylate Tablets 400mg PACK : 30s Bottle BATCH DETAILS AS PER DOCUMENT	$50.0K	1

SUN Pharmaceutical Industries Limited exports 56 distinct Imatinib formulations including tablets, capsules, syrups, and combination drugs. The top formulation is IMATINIB Mesylate Tablets 400mg PACK : 30s Bottle Batch No. with 4 shipments worth $200.0K.

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Imatinib Exporters?

Exporters ranked immediately above and below #3 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	CIPLA LIMITED	$5.2M	103	8	$50.0K
2	EUGIA PHARMA SPECIALITIES LIMITED	$4.1M	82	2	$50.0K
3	SUN PHARMACEUTICAL INDUSTRIES LIMITED ★	$2.9M	72	7	$40.3K
4	JODAS EXPOIM PRIVATE LIMITED	$1.9M	38	3	$50.0K
5	NATCO PHARMA LIMITED	$1.3M	33	9	$39.7K

SUN Pharmaceutical Industries Limited ranks #3 among 224 Indian Imatinib exporters. Average shipment value of $40.3K compared to the market average of $82.5K. The closest competitors by value are CIPLA LIMITED and EUGIA PHARMA SPECIALITIES LIMITED.

Which Indian Ports Ship Imatinib Exports?

Port	Shipments	% Share
SAHAR AIR	314	18.2%
SAHAR AIR CARGO ACC (INBOM4)	301	17.4%
DELHI AIR CARGO ACC (INDEL4)	235	13.6%
DELHI AIR	142	8.2%
Bombay Air	123	7.1%
HYDERABAD AIR	69	4.0%
HYDERABAD ACC (INHYD4)	61	3.5%
AHEMDABAD AIR	35	2.0%

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Imatinib Exports

Sun Pharma's export operations, valued at $979.8 million, are significantly influenced by current geopolitical events. The ongoing Israel-Iran tensions have led to disruptions in the Red Sea shipping routes, a critical corridor for Indian pharmaceutical exports to Europe and North Africa. Major shipping lines have imposed 'Emergency Risk Surcharges,' increasing freight costs and extending transit times by 10–15 days. These delays pose risks to the integrity of time-sensitive and temperature-controlled pharmaceutical shipments. (pharmaceuticalcommerce.com)

In the United States, policy shifts towards domestic manufacturing and the imposition of tariffs on imported pharmaceuticals have created challenges for Indian exporters. Sun Pharma, which supplies a substantial portion of generics to the U.S. market, faces potential reductions in export volumes due to these protectionist measures. The company is exploring strategies such as establishing local partnerships and investing in U.S.-based manufacturing to mitigate these impacts. (odrindia.in)

The European Union's implementation of the Carbon Border Adjustment Mechanism (CBAM) introduces additional compliance requirements for exporters. Sun Pharma must adapt to these regulations to maintain its market presence in the EU, necessitating investments in sustainable manufacturing practices and comprehensive reporting mechanisms. (sgeexport.com)

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards remains a critical focus for Sun Pharma. The company has encountered challenges with the U.S. FDA, including import alerts and non-compliance letters for certain facilities. Addressing these issues involves implementing corrective actions and awaiting reinspection to resume full operations. (business-standard.com)

Globally, the pharmaceutical industry faces increasing scrutiny regarding quality standards. Sun Pharma's commitment to adhering to Good Manufacturing Practices (GMP) and other regulatory requirements is essential to maintain its export licenses and market reputation. Continuous investment in quality control systems and compliance infrastructure is imperative to navigate the evolving regulatory landscape.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Imatinib shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: SUN Pharmaceutical Industries Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 76 individual customs records matching SUN Pharmaceutical Industries Limited exporting Imatinib, covering 56 formulations to 7 countries via 18 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 119+ countries, 456+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Imatinib

Imatinib

SUN Pharmaceutical Industries Limited — Imatinib Exporter Profile

SUN Pharmaceutical Industries Limited — Imatinib Export Profile: Buyers & Destinations

Where Does SUN Pharmaceutical Industries Limited Export Imatinib?

Who Are the Top Buyers of Imatinib from SUN Pharmaceutical Industries Limited?

What Is India's Total Imatinib Export Value and How Much Does SUN Pharmaceutical Industries Limited Contribute?

What Is the Average Shipment Value for SUN Pharmaceutical Industries Limited's Imatinib Exports?

How Does SUN Pharmaceutical Industries Limited Compare to Other Indian Imatinib Exporters?

What Imatinib Formulations Does SUN Pharmaceutical Industries Limited Export?

Regulatory Requirements: Exporting Imatinib to Key Markets

United States — FDA

Australia — TGA

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Imatinib Exporters?

Which Indian Ports Ship Imatinib Exports?

Imatinib — Export Intelligence Video

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Imatinib Exports

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

About SUN Pharmaceutical Industries Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Imatinib Export Data from SUN Pharmaceutical Industries Limited

Imatinib Stats

Company Overview

Top Products by SUN Pharmaceutical Industries Limited

Related Analysis

Need Detailed Export Data?

Data Source